Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 217

1.

Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment.

Shimada A, Tsushima T, Tsubosa Y, Booka E, Takebayashi K, Niihara M, Isaka M, Ohde Y, Machida N, Onozawa Y, Yasui H, Takeuchi H, Kitagawa Y.

World J Surg. 2019 Jan 23. doi: 10.1007/s00268-018-04904-w. [Epub ahead of print]

PMID:
30675631
2.

Preventive Effect of Nutrition Support on Peroneal Neuropathy in Cancer Patients.

Fukuda H, Yamashita A, Imai T, Tsumaki H, Nagata N, Ishikawa H, Niihara M, Tsubosa Y, Onozawa Y.

Front Nutr. 2019 Jan 8;5:139. doi: 10.3389/fnut.2018.00139. eCollection 2018.

3.

Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Hamauchi S, Yokota T, Mizumachi T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H, Homma A.

Int J Clin Oncol. 2019 Jan 17. doi: 10.1007/s10147-018-01392-9. [Epub ahead of print]

PMID:
30656463
4.

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.

Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K.

J Clin Oncol. 2019 Jan 17:JCO1800771. doi: 10.1200/JCO.18.00771. [Epub ahead of print]

PMID:
30653423
5.

[The Incidence and Management of Hypersensitivity and Infusion Reactions in an Outpatient Chemotherapy Center].

Sekine H, Akaiwa A, Onozawa Y, Kinjo T, Nakamura H, Nakamura R, Nawa M, Yoshida S, Araki N, Iizuka M, Shimizu H, Sunaga N, Tsukamoto N.

Gan To Kagaku Ryoho. 2018 Nov;45(11):1625-1629. Japanese.

PMID:
30449851
6.

Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2).

Matsuzuka T, Kiyota N, Mizusawa J, Akimoto T, Fujii M, Hasegawa Y, Iwae S, Monden N, Matsuura K, Onozawa Y, Hayashi R, Tahara M; Japan Clinical Oncology Group(JCOG) Head and Neck Cancer Study Group.

Jpn J Clin Oncol. 2019 Jan 1;49(1):37-41. doi: 10.1093/jjco/hyy145.

PMID:
30364985
7.

Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.

Kawahira M, Yokota T, Hamauchi S, Kawai S, Yoshida Y, Onozawa Y, Tsushima T, Todaka A, Machida N, Yamazaki K, Fukutomi A, Yasui H.

Int J Clin Oncol. 2018 Dec;23(6):1189-1195. doi: 10.1007/s10147-018-1306-3. Epub 2018 Jun 15.

PMID:
29948238
8.

Phase II study of S-1 plus oxaliplatin 130 mg/m2 in Japanese patients with advanced gastric cancer.

Kito Y, Machida N, Kawai S, Hamauchi S, Tsushima T, Todaka A, Yokota T, Yamazaki K, Fukutomi A, Onozawa Y, Tsuji K, Doyama H, Haraguchi Y, Nakashima K, Kunieda K, Taku K, Mori K, Yasui H.

Int J Clin Oncol. 2018 Jun 21. doi: 10.1007/s10147-018-1308-1. [Epub ahead of print]

PMID:
29931597
9.

Association between N-methyl-D-aspartate Receptor Subunit 2B Gene Polymorphisms and Personality Traits in a Young Japanese Population.

Narita S, Onozawa Y, Yoshihara E, Nishizawa D, Numajiri M, Ikeda K, Iwahashi K.

East Asian Arch Psychiatry. 2018 Jun;28(2):45-52.

10.

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.

Kawakami T, Tsushima T, Omae K, Ogawa H, Shirasu H, Kito Y, Yoshida Y, Hamauchi S, Todaka A, Machida N, Yokota T, Yamazaki K, Fukutomi A, Onozawa Y, Yasui H.

BMC Cancer. 2018 May 18;18(1):573. doi: 10.1186/s12885-018-4486-3.

11.

Evoked potential studies for predicting functional recovery in a case of acute necrotizing encephalopathy.

Onozawa Y, Iwasaki T, Iizuka T, Nonoda Y, Toki T, Obata S, Munekata S, Kanoh Y.

Clin Case Rep. 2018 Mar 8;6(5):813-816. doi: 10.1002/ccr3.1473. eCollection 2018 May.

12.

Gastrojejunostomy versus duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer.

Yoshida Y, Fukutomi A, Tanaka M, Sugiura T, Kawata N, Kawai S, Kito Y, Hamauchi S, Tsushima T, Yokota T, Todaka A, Machida N, Yamazaki K, Onozawa Y, Yasui H.

Pancreatology. 2017 Nov - Dec;17(6):983-989. doi: 10.1016/j.pan.2017.09.011. Epub 2017 Oct 3.

PMID:
29066391
13.

No Association between the Polymorphism rs6943555 in the AUTS2 Gene and Personality Traits in Japanese University Students.

Narita S, Ikeda K, Nishizawa D, Yoshihara E, Numajiri M, Onozawa Y, Ohtani N, Iwahashi K.

Psychiatry Investig. 2017 Sep;14(5):681-686. doi: 10.4306/pi.2017.14.5.681. Epub 2017 Sep 11.

14.

Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy.

Iizuka T, Kanazawa N, Kaneko J, Tominaga N, Nonoda Y, Hara A, Onozawa Y, Asari H, Hata T, Kaneko J, Yoshida K, Sugiura Y, Ugawa Y, Watanabe M, Tomita H, Kosakai A, Kaneko A, Ishima D, Kitamura E, Nishiyama K.

Neurol Neuroimmunol Neuroinflamm. 2017 Sep 25;4(6):e396. doi: 10.1212/NXI.0000000000000396. eCollection 2017 Nov.

15.

Magnifying Endoscopy with Blue Laser Imaging Improves the Microstructure Visualization in Early Gastric Cancer: Comparison of Magnifying Endoscopy with Narrow-Band Imaging.

Kimura-Tsuchiya R, Dohi O, Fujita Y, Yagi N, Majima A, Horii Y, Kitaichi T, Onozawa Y, Suzuki K, Tomie A, Okayama T, Yoshida N, Kamada K, Katada K, Uchiyama K, Ishikawa T, Takagi T, Handa O, Konishi H, Kishimoto M, Naito Y, Yanagisawa A, Itoh Y.

Gastroenterol Res Pract. 2017;2017:8303046. doi: 10.1155/2017/8303046. Epub 2017 Aug 30.

16.

Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.

Komori A, Taniguchi H, Hamauchi S, Masuishi T, Kito Y, Narita Y, Tsushima T, Ishihara M, Todaka A, Tanaka T, Yokota T, Kadowaki S, Machida N, Ura T, Fukutomi A, Ando M, Onozawa Y, Tajika M, Yasui H, Muro K, Mori K, Yamazaki K.

Oncology. 2017;93(5):329-335. doi: 10.1159/000479280. Epub 2017 Sep 2.

PMID:
28866662
17.

F-36316 A and B, novel vasoactive compounds, isolated from Incrucipulum sp. SANK 10414.

Hirota-Takahata Y, Ishimoto Y, Kurosawa E, Iwadate Y, Onozawa Y, Tanaka I, Tanaka M, Kobayashi H.

J Antibiot (Tokyo). 2017 Oct;70(10):981-986. doi: 10.1038/ja.2017.84. Epub 2017 Aug 9.

PMID:
28792011
18.

Role of hepatectomy in gastric cancer with multiple liver-limited metastases.

Shirasu H, Tsushima T, Kawahira M, Kawai S, Kawakami T, Kito Y, Yoshida Y, Hamauchi S, Todaka A, Yokota T, Machida N, Yamazaki K, Fukutomi A, Onozawa Y, Terashima M, Uesaka K, Yasui H.

Gastric Cancer. 2018 Mar;21(2):338-344. doi: 10.1007/s10120-017-0730-9. Epub 2017 Jun 2.

PMID:
28577228
19.

Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3.

Kawahira M, Yokota T, Hamauchi S, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H.

Jpn J Clin Oncol. 2017 Aug 1;47(8):705-712. doi: 10.1093/jjco/hyx057.

PMID:
28431119
20.

Immunoglobulin G4-related sclerosing cholangitis diagnosed by liver biopsy: a case report.

Furuta M, Eguchi H, Takeda Y, Fushiki K, Yasuda T, Onozawa Y, Katayama M, Tanaka M, Shigematsu T, Bamba M.

Nihon Shokakibyo Gakkai Zasshi. 2017;114(3):464-472. doi: 10.11405/nisshoshi.114.464. Review. Japanese.

PMID:
28260715
21.

Real-time monitoring of trans-epithelial electrical resistance in cultured intestinal epithelial cells: the barrier protection of water-soluble dietary fiber.

Majima A, Handa O, Naito Y, Suyama Y, Onozawa Y, Higashimura Y, Mizushima K, Morita M, Uehara Y, Horie H, Iida T, Fukui A, Dohi O, Okayama T, Yoshida N, Kamada K, Katada K, Uchiyama K, Ishikawa T, Takagi T, Konishi H, Yasukawa Z, Tokunaga M, Okubo T, Itoh Y.

J Dig Dis. 2017 Mar;18(3):151-159. doi: 10.1111/1751-2980.12456.

PMID:
28139083
22.

Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.

Kawai S, Yokota T, Onozawa Y, Hamauchi S, Fukutomi A, Ogawa H, Onoe T, Onitsuka T, Yurikusa T, Todaka A, Tsushima T, Yoshida Y, Kito Y, Mori K, Yasui H.

BMC Cancer. 2017 Jan 17;17(1):59. doi: 10.1186/s12885-017-3052-8.

23.

Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer.

Takebayashi K, Tsubosa Y, Matsuda S, Kawamorita K, Niihara M, Tsushima T, Yokota T, Sato H, Onozawa Y, Ogawa H, Kamijo T, Onitsuka T, Nakagawa M, Yasui H.

Dis Esophagus. 2017 Feb 1;30(2):1-5. doi: 10.1111/dote.12502.

PMID:
27859977
24.

A Novel Natural Product-Derived Compound, Vestaine A1, Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF.

Ishimoto Y, Hirota-Takahata Y, Kurosawa E, Chiba J, Iwadate Y, Onozawa Y, Hasegawa T, Tamura A, Tanaka M, Kobayashi H.

Cell Physiol Biochem. 2016;39(5):1905-1918. Epub 2016 Oct 24.

25.

Blue Laser Imaging-Bright Improves Endoscopic Recognition of Superficial Esophageal Squamous Cell Carcinoma.

Tomie A, Dohi O, Yagi N, Kitae H, Majima A, Horii Y, Kitaichi T, Onozawa Y, Suzuki K, Kimura-Tsuchiya R, Okayama T, Yoshida N, Kamada K, Katada K, Uchiyama K, Ishikawa T, Takagi T, Handa O, Konishi H, Naito Y, Itoh Y.

Gastroenterol Res Pract. 2016;2016:6140854. Epub 2016 Sep 22.

26.

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.

Masuishi T, Taniguchi H, Hamauchi S, Komori A, Kito Y, Narita Y, Tsushima T, Ishihara M, Todaka A, Tanaka T, Yokota T, Kadowaki S, Machida N, Ura T, Fukutomi A, Ando M, Onozawa Y, Tajika M, Yasui H, Muro K, Mori K, Yamazaki K.

Clin Colorectal Cancer. 2017 Jun;16(2):e15-e22. doi: 10.1016/j.clcc.2016.07.019. Epub 2016 Aug 31.

PMID:
27670892
27.

No Relationships between Psychosis and the Diazepam Binding Inhibitor rs2276596 (C/A) Polymorphism in Japanese: An Exploratory Study.

Yoshiharia E, Narita S, Waga C, Numajiri M, Onozawa Y, Iwahashi K.

Rinsho Byori. 2016 Sep;64(9):1007-1011.

PMID:
30609452
28.

Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer.

Kawakami T, Machida N, Yasui H, Kawahira M, Kawai S, Kito Y, Yoshida Y, Hamauchi S, Tsushima T, Todaka A, Yokota T, Yamazaki K, Fukutomi A, Onozawa Y.

Cancer Chemother Pharmacol. 2016 Oct;78(4):809-14. doi: 10.1007/s00280-016-3138-z. Epub 2016 Aug 26.

PMID:
27566700
29.

Linked color imaging improves endoscopic diagnosis of active Helicobacter pylori infection.

Dohi O, Yagi N, Onozawa Y, Kimura-Tsuchiya R, Majima A, Kitaichi T, Horii Y, Suzuki K, Tomie A, Okayama T, Yoshida N, Kamada K, Katada K, Uchiyama K, Ishikawa T, Takagi T, Handa O, Konishi H, Naito Y, Itoh Y.

Endosc Int Open. 2016 Jul;4(7):E800-5. doi: 10.1055/s-0042-109049.

30.

Autoimmune brachial amyotrophic diplegia and sensory neuronopathy with Sjögren's syndrome: A case report.

Tominaga N, Iizuka T, Kaneko J, Nagai M, Hara A, Onozawa Y, Kanazawa N, Nishiyama K.

J Neurol Sci. 2016 Sep 15;368:1-3. doi: 10.1016/j.jns.2016.06.053. Epub 2016 Jun 25. No abstract available.

PMID:
27538592
31.

Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102.

Hamauchi S, Yamazaki K, Masuishi T, Kito Y, Komori A, Tsushima T, Narita Y, Todaka A, Ishihara M, Yokota T, Tanaka T, Machida N, Kadowaki S, Fukutomi A, Ura T, Onozawa Y, Ando M, Tajika M, Muro K, Yasui H, Mori K, Taniguchi H.

Clin Colorectal Cancer. 2017 Mar;16(1):51-57. doi: 10.1016/j.clcc.2016.07.005. Epub 2016 Jul 21.

PMID:
27522626
32.

Diagnostic ability of magnifying endoscopy with blue laser imaging for early gastric cancer: a prospective study.

Dohi O, Yagi N, Majima A, Horii Y, Kitaichi T, Onozawa Y, Suzuki K, Tomie A, Kimura-Tsuchiya R, Tsuji T, Yamada N, Bito N, Okayama T, Yoshida N, Kamada K, Katada K, Uchiyama K, Ishikawa T, Takagi T, Handa O, Konishi H, Naito Y, Yanagisawa A, Itoh Y.

Gastric Cancer. 2017 Mar;20(2):297-303. doi: 10.1007/s10120-016-0620-6. Epub 2016 Jun 13.

PMID:
27294430
33.

Prognostic Factors and Multidisciplinary Postoperative Chemoradiotherapy for Clinical T4a Tongue Cancer.

Yokota T, Iida Y, Ogawa H, Kamijo T, Onozawa Y, Todaka A, Hamauchi S, Onoe T, Nakagawa M, Yurikusa T, Tanuma A, Yamashita A, Nishimura T, Yasui H, Onitsuka T.

Oncology. 2016;91(2):78-84. doi: 10.1159/000446439. Epub 2016 Jun 7.

PMID:
27270420
34.

[Posterior Reversible Encephalopathy Syndrome Associated with Cancer Therapy].

Mitsuya K, Nakasu Y, Hayashi N, Yasui H, Ikeda T, Kuji S, Onozawa Y, Endo M.

No Shinkei Geka. 2016 Mar;44(3):211-9. doi: 10.11477/mf.1436203259. Japanese.

PMID:
26965062
35.

Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.

Matsuda S, Tsubosa Y, Sato H, Takebayashi K, Kawamorita K, Mori K, Niihara M, Tsushima T, Yokota T, Onozawa Y, Yasui H, Takeuchi H, Kitagawa Y.

Dis Esophagus. 2017 Feb 1;30(2):1-8. doi: 10.1111/dote.12473.

PMID:
26919154
36.

Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin.

Horie Y, Yamazaki K, Funakoshi T, Hamauchi S, Taniguchi H, Tsushima T, Todaka A, Machida N, Taku K, Fukutomi A, Onozawa Y, Yasui H, Mizukami T, Izawa N, Hirakawa M, Tsuda T, Nakajima T, Boku N.

Mol Clin Oncol. 2015 Sep;3(5):1029-1034. Epub 2015 Jun 24.

37.

Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Hamauchi S, Yokota T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H.

Jpn J Clin Oncol. 2015 Dec;45(12):1116-21. doi: 10.1093/jjco/hyv142. Epub 2015 Sep 29.

PMID:
26423341
38.

[Intraoperative ABR Monitoring in Neurosurgery].

Sato S, Onozawa Y, Kumabe T, Okamoto H.

Masui. 2015 May;64(5):502-7. Japanese.

PMID:
26422957
39.

Risk Analysis of Pneumonitis in Taxane Therapy After Chemoradiotherapy for Patients With Metastatic or Recurrent Esophageal Cancer.

Kishida Y, Tsushima T, Endo M, Hamauchi S, Todaka A, Yokota T, Machida N, Yamazaki K, Fukutomi A, Onozawa Y, Yasui H.

Am J Clin Oncol. 2018 Jan;41(1):41-45. doi: 10.1097/COC.0000000000000232.

PMID:
26422718
40.

Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy.

Tabuse H, Kashiwagi H, Hamauchi S, Tsushima T, Todaka A, Yokota T, Machida N, Yamazaki K, Fukutomi A, Onozawa Y, Mori K, Boku N, Ichinose M, Yasui H.

Gastric Cancer. 2016 Jul;19(3):894-901. doi: 10.1007/s10120-015-0540-x. Epub 2015 Sep 11.

PMID:
26362271
41.

Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary.

Takeuchi H, Saeki T, Aiba K, Tamura K, Aogi K, Eguchi K, Okita K, Kagami Y, Tanaka R, Nakagawa K, Fujii H, Boku N, Wada M, Akechi T, Udagawa Y, Okawa Y, Onozawa Y, Sasaki H, Shima Y, Shimoyama N, Takeda M, Nishidate T, Yamamoto A, Ikeda T, Hirata K.

Int J Clin Oncol. 2016 Feb;21(1):1-12. doi: 10.1007/s10147-015-0852-1. Epub 2015 Jun 17.

42.

Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer.

Nozawa M, Mukai H, Takahashi S, Uemura H, Kosaka T, Onozawa Y, Miyazaki J, Suzuki K, Okihara K, Arai Y, Kamba T, Kato M, Nakai Y, Furuse H, Kume H, Ide H, Kitamura H, Yokomizo A, Kimura T, Tomita Y, Ohno K, Kakehi Y.

Int J Clin Oncol. 2015 Oct;20(5):1026-34. doi: 10.1007/s10147-015-0820-9. Epub 2015 Mar 26.

PMID:
25809824
43.

Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706).

Tahara M, Kiyota N, Mizusawa J, Nakamura K, Hayashi R, Akimoto T, Hasegawa Y, Iwae S, Monden N, Matsuura K, Fujii H, Onozawa Y, Homma A, Kubota A, Fukuda H, Fujii M.

Cancer Sci. 2015 Jun;106(6):726-33. doi: 10.1111/cas.12657. Epub 2015 Apr 1.

44.

Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.

Matsuda S, Tsubosa Y, Niihara M, Sato H, Takebayashi K, Kawamorita K, Mori K, Tsushima T, Yokota T, Ogawa H, Onozawa Y, Yasui H, Takeuchi H, Kitagawa Y.

Ann Surg Oncol. 2015;22(6):1866-73. doi: 10.1245/s10434-014-4337-7. Epub 2015 Jan 7.

PMID:
25564176
45.

Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases.

Izawa N, Onozawa Y, Hikosaka T, Hamauchi S, Tsushima T, Todaka A, Machida N, Haraguchi Y, Ogawa H, Nishimura T, Nakagawa M, Fuke T, Iida Y, Kamijo T, Onitsuka T, Boku N, Yasui H, Yokota T.

Int J Clin Oncol. 2015 Jun;20(3):455-62. doi: 10.1007/s10147-014-0749-4. Epub 2014 Sep 25.

PMID:
25248339
46.

Phase I study of Efatutazone, an oral PPARγ agonist, in patients with metastatic solid tumors.

Murakami H, Ono A, Takahashi T, Onozawa Y, Tsushima T, Yamazaki K, Jikoh T, Boku N, Yamamoto N.

Anticancer Res. 2014 Sep;34(9):5133-41.

PMID:
25202104
47.

[Carcinoma unknown primary-clinical practice].

Onozawa Y.

Gan To Kagaku Ryoho. 2014 Jul;41(7):799-803. Review. Japanese.

PMID:
25131862
48.

Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors.

Doi T, Onozawa Y, Fuse N, Yoshino T, Yamazaki K, Watanabe J, Akimov M, Robson M, Boku N, Ohtsu A.

Cancer Chemother Pharmacol. 2014 Sep;74(3):629-36. doi: 10.1007/s00280-014-2521-x. Epub 2014 Jul 25.

49.

Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa.

Funakoshi T, Yasui H, Boku N, Fukutomi A, Yamazaki K, Machida N, Todaka A, Tsushima T, Yokota T, Onozawa Y, Kenmotsu H, Endo M.

Jpn J Clin Oncol. 2014 Sep;44(9):792-8. doi: 10.1093/jjco/hyu091. Epub 2014 Jul 23.

PMID:
25057093
50.

Haplotype analysis of GSK-3β gene polymorphisms in bipolar disorder lithium responders and nonresponders.

Iwahashi K, Nishizawa D, Narita S, Numajiri M, Murayama O, Yoshihara E, Onozawa Y, Nagahori K, Fukamauchi F, Ikeda K, Ishigooka J.

Clin Neuropharmacol. 2014 Jul-Aug;37(4):108-10. doi: 10.1097/WNF.0000000000000039.

Supplemental Content

Loading ...
Support Center